CIK 0001540159
- Non-accelerated filer
- Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 905-475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-12 | Chun Paul Director | Grant or award · Share Option (Right to Buy) | +357 | 357 | ||
| 2018-03-12 | Chun Paul Director | Grant or award · Share Option (Right to Buy) | +2,500 | 2,500 | ||
| 2017-03-23 | Chun Paul Director | Grant or award · Share Option (Right to Buy) | +2,500 | 2,500 | ||
| 2016-12-20 | Chun Paul Director | Grant or award · Share Option (Right to Buy) | +2,500 | 2,500 |
Page 1 of 1 · 4 trades